Expand your clinical capability
Enhance your productivity
Capitalize on your investment

A better balance between image quality and dose.

PUREViSION Optics

PUREOptics provides significantly improved imaging efficiency from photon generation to detection. An optimized beam spectrum combined with a more efficient detector result in a better balance between image quality and dose.

Patient specific beam shaping filters provide an optimized X-ray spectrum and more homogenous distribution, improving low contrast detectability by up to:
  • 19% improved LCD at equivalent dose—brain*
  • 22% improved LCD at equivalent dose—body*
  • 31% dose reduction at equivalent low contrast detectability*
*A non-prewhitening model observer study was conducted comparing Aquilion Prime SP to the Aquilion PRIME. Dose reduction values were established by comparing low contrast detectability under baseline conditions for abdominal and brain examination.Based on the detectability index performance metric, a measure of signal to noise that takes into account the magnitude and texture of both the signal and the noise for a given LCD task.

Watch PUREViSION Optics video

Enhanced Iodine Imaging

Angiography SURESubtraction CT & Iodine Mapping SURESubtraction CT

Upgrade every multi phase CT protocol with enhanced iodine imaging that provides whole organ perfusion, improves the visualization of subtle lesions, and provides an excellent view of vessel lumens that is free from calcium stents and bone.

SURE Subtraction Read the scientific article on Ultra-High Resolution Subtraction CT Watch clinical cases using SCT technology

Adaptive Iterative Dose Reduction integrated into

AIDR 3D

AIDR 3D has been developed as the next step in the evolution of noise reduction technology. This iterative algorithm removes noise in the raw and image data space, by analyzing and processing the data repeatedly.
Learn More About AIDR 3D

Automated technique for kV selection

SUREkV

  • Integrated and easy to use radiation dose management
  • Automated kV selection based on patient size, SUREExposure settings and clinical task
  • Clinically targeted kV selections of: 80, 100, 120, 135

Aortic CTA acquired with vHP, Heart Rate of 86 bpm, 40 ml of iodinated contrast material, SUREkV (100 kV automatically selected).